Welcome to our dedicated page for BUUU Group SEC filings (Ticker: BUUU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BUUU Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BUUU Group's regulatory disclosures and financial reporting.
BUUU Group Limited reported that its board of directors and compensation committee approved a new 2025 Equity Incentive Plan on September 23, 2025, effective the same day. The plan authorizes a maximum aggregate of 2,000,000 Class A ordinary shares for issuance. It is designed to motivate, attract and retain directors, consultants, and key employees and to align their personal interests with those of the company’s shareholders through equity-based awards. The full text of the 2025 Equity Incentive Plan is included as an exhibit to the report.
BUUU Group Limited, a Hong Kong–based company incorporated in the British Virgin Islands, entered into an underwriting agreement for a firm commitment initial public offering of 1,500,000 Class A ordinary shares at $4.00 per share.
The underwriters received a 45-day over-allotment option for up to 225,000 additional shares. On August 27, 2025, the representative partially exercised this option to buy 175,000 additional Class A ordinary shares at the same public offering price, with the over-allotment closing on September 3, 2025.
Including the exercised over-allotment, the company’s IPO generated total gross proceeds of approximately $6.7 million before underwriting discounts and related expenses.